Beirne Wealth Consulting Services, LLC Novavax Inc Transaction History
Beirne Wealth Consulting Services, LLC
- $281 Billion
- Q1 2025
A detailed history of Beirne Wealth Consulting Services, LLC transactions in Novavax Inc stock. As of the latest transaction made, Beirne Wealth Consulting Services, LLC holds 10,000 shares of NVAX stock, worth $62,699. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000
Previous 16,500
39.39%
Holding current value
$62,699
Previous $133 Million
51.68%
% of portfolio
0.02%
Previous 0.05%
Shares
14 transactions
Others Institutions Holding NVAX
# of Institutions
286Shares Held
93.2MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$98.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$74.3 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$69.9 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$48.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$36.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $490M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...